Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong - Concepedia

Concepedia

Publication | Closed Access

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

17

Citations

11

References

2016

Year

Henry Lik‐Yuen Chan, Owen Tak‐Yin Tsang, Yee‐Tak Hui, James Fung, Grace Lui, Ching‐Lung Lai, Grace Lai–Hung Wong, Kam‐Hon Chan, David Yiu‐Kuen But, Moon‐Sing Lai,

Journal of Gastroenterology and Hepatology

Abstract

Paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin is effective and safe in patients with genotype 1 HCV infection in real-life clinical setting in Hong Kong.

References

	Year	Citations

Page 1